Live Streaming
- 연수평점 신청을 원하시는 분은 아래 온라인 출결시스템에서 출결 체크를 해주시기 바랍니다.
- 세션 체류시간 1시간당 1평점이 인정되며, 최대 6평점 이수가 가능합니다.
- 운영사무국 Tel. 02-2038-7939 Email iass2022@humming.co.kr
- 세션 체류시간 1시간당 1평점이 인정되며, 최대 6평점 이수가 가능합니다.
- 운영사무국 Tel. 02-2038-7939 Email iass2022@humming.co.kr
온라인 연수평점 출결시스템
DAY 1 - Saturday, June 4th, 2022
| 시간 | 프로그램명 | 연사 | 출결 확인 |
|---|---|---|---|
| Session 1 09:30-11:00 | The understandings of immunopathophysiology of atopic dermatitis | Chair Eun-So Lee Ajou University Hospital | 시작 종료 |
| 09:30-10:00 | Mechanistic insights into IL-13 in atopic dermatitis pathophysiology | Dong-Hun Lee Seoul National University Hospital | |
| 10:00-10:30 | Immunopathologic consideration and characteristics in atopic dermatitis compared with psoriasis | Tae-Young Han Eulji University, Nowon Eulji Medical Center | |
| 10:30-11:00 | How about the others such as TH17 & 22 in atopic dermatitis pathogenesis? | Yong-Hyun Jang Kyungpook National University Hospital | |
| Session 2 11:20-12:00 | Special lecture Ⅰ | Chair Seong-Jun Seo Chung-Ang University Hospital | 시작 종료 |
| 11:20-12:00 | Safety of JAK inhibitors: lessons from rheumatology experiences | Seoyoung C. Kim Brigham and Women’s Hospital and Harvard Medical School, USA | |
| Luncheon 12:00-13:20 | Abbvie sponsored lecture | Chair Jee-Bum Lee Chonnam National University Hospital | 시작 종료 |
| 12:00-12:40 | What should be the 1st option for moderate to severe atopic dermatitis patients? Deep dive in H2H data between JAKi vs biologics | Kilian Eyerich University of Freiburg, Karolinska Institutet, Sweden | |
| Session 3 13:20-14:10 | Special lecture Ⅱ | Chair Sang-Hyun Cho The Catholic University of Korea, Incheon St. Mary’s Hospital | 시작 종료 |
| 13:20-14:10 | Role of IL-17A producing innate lymphoid cells in the pathogenesis of atopic dermatitis | Kyu-Han Kim Seoul National University Hospital | |
| Session 4 14:10-15:10 | Diagnosis and treatment approach in childhood and elderly atopic dermatitis | Chair Chun-Wook Park Hallym University, Kangnam Sacred Heart Hospital | 시작 종료 |
| 14:10-14:40 | Clinical characteristics and a new treatment challenge in children atopic dermatitis | Sang-Eun Lee Yonsei University College of Medicine, Gangnam Severance Hospital | |
| 14:40-15:10 | The needs for definition and diagnostic criteria of elderly atopic dermatitis | Min-Kyung Shin Kyung Hee University Medical Center | |
| Session 5 15:30-16:35 | Evolving practice in atopic dermatitis | Chair Young-Lip Park Soonchunhyang University, Bucheon Hospital | 시작 종료 |
| 15:30-16:10 | Restoration of skin barrier function in atopic dermatitis: Goal or consequence of targeted therapy? | Hyun Jong Kim Sejong Chungnam National University Hospital | |
| 16:10-16:35 | Evolving practice guidelines in atopic dermatitis | Hyun-Chang Ko Pusan National University Hospital | |
| Session 6 16:35-17:10 | Special lecture III | Chair Moon-Bum Kim Pusan National University Yangsan Hospital | 시작 종료 |
| 16:35-17:10 | The burden and pathophysiology of atopic dermatitis and the benefits of JAK1 inhibition | Michael Ardern-Jones University of Southampton, UK |
DAY 2 - Sunday, June 5th, 2022
| 시간 | 프로그램명 | 연사 | 출결 확인 |
|---|---|---|---|
| Session 7 09:30-10:40 | The itch in atopic dermatitis | Chair Sang-Wook Son Korea University Ansan Hospital | 시작 종료 |
| 09:30-10:10 | The mechanism and characteristics of itch in atopic dermatitis | Brian Kim Mount Sinai West, USA | |
| 10:10-10:40 | Optimal management of itch in atopic dermatitis : therapeutic apporoaches | Jiehyun Jeon Korea University Guro Hospital | |
| Session 8 11:00-12:10 | Pfizer sponsored lecture | Chair Eung-Ho Choi Wonju Severance Christian Hospital | 시작 종료 |
| 11:00-11:40 | Real-life experience with new innovative therapies, Abrocitinib | Adelaide A. HebertMcGovern Medical School, USA | |
| 11:40-12:10 | Emerging agent: What we can learn from the JADE clinical program | Joo-Yeon Ko Hanyang University Hospital | |
| Luncheon 12:10-13:30 | Sanofi sponsored lecture | Chair Kyu-Han Kim Seoul National University Hospital | 시작 종료 |
| 12:10-12:50 | Towards a long term disease control in atopic dermatitis and evolving treatments | Emma Guttman-Yassky Mount Sinai Morningside and Mount Sinai West, USA | |
| Session 9 13:30-14:20 | Preparing for a new dawn in atopic dermatitis treatments: promising therapies | Chair Young-Min Park The Catholic University of Korea, Seoul St. Mary’s Hospital | 시작 종료 |
| 13:30-13:50 | Overview of emerging biologic therapies under clinical trials | Ji Hyun Lee The Catholic University of Korea, Seoul St. Mary’s Hospital | |
| 13:50-14:20 | Effects and safety of upcoming therapies other than biologics | Hye-One Kim Hallym University, Kangnam Sacred Heart Hospital | |
| Session 10 14:20-15:30 | Striving for advanced care in atopic dermatitis | Chair Joo-Young Roh Ewha Womans University Seoul Hospital | 시작 종료 |
| 14:20-15:00 | Raising the bar in atopic dermatitis management | Chia-Yu CHU National Taiwan University, Taiwan | |
| 15:00-15:30 | Journey of advance : Better standard of care for atopic dermatitis patients | Ji-Young Ahn National Medical Center | |
| Session 11 15:50-17:00 | Lilly sponsored lecture | Chair Sung-Eun Chang University of Ulsan, Asan Medical Center | 시작 종료 |
| 15:50-16:30 | Baricitinib for moderate to severe atopic dermatitis : Treatment experience in Germany | Stephan Weidinger Kiel, Germany | |
| 16:30-17:00 | How to prescribe baricitinib : my experience | Chan-Ho Na Chosun University Hospital |
This page can only be viewed by logged in members.